Innovative Diagnostics Vascular BioSciences specializes in advanced interventional catheters and molecular diagnostic services targeting pulmonary conditions, presenting opportunities to collaborate with hospitals and clinics focused on pulmonary health and personalized medicine.
Research and Development Expansion Recent publications and the launch of a pig model for pulmonary hypertension indicate ongoing investment in research, opening chances to engage with contract research organizations and biotech firms looking for innovative tools and services.
Strategic Partnerships The addition of seasoned advisors in bioinformatics and vascular biology suggests a focus on cutting-edge research and product development, creating avenues to approach biotech and pharmaceutical companies interested in targeted therapies and diagnostic advancements.
Funding and Growth Although revenue is modest, recent grants and strategic hires demonstrate growth potential; sales efforts could target government agencies, research institutions, and biotech investors looking to support innovative cardiovascular research.
Technology Integration The company's utilization of advanced tech stacks and data-driven tools indicates a focus on innovative solutions, making it a promising partner for digital health firms and technology providers seeking to enhance biotech research and diagnostic capabilities.
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10BVascular BioSciences uses 8 technology products and services including RSS, MySQL, oEmbed, and more. Explore Vascular BioSciences's tech stack below.
| Vascular BioSciences Email Formats | Percentage |
| FLast@vascularbiosciences.com | 47% |
| Last@vascularbiosciences.com | 3% |
| F.Last@vascularbiosciences.com | 3% |
| FLast@vascularbiosciences.com | 47% |
Biotechnology ResearchUnited States11-50 Employees
Vascular BioSciences (VBS), a biomedical company with operations in Research Triangle, NC, San Diego, and Goleta, CA, makes interventional catheters to obtain pulmonary endoarterial biopsies, provides molecular diagnostic services, and through its majority-owned subsidiary, VBS Pharmaceuticals, advances targeted therapies in order to enhance and prolong human life.
Company Overview
Media & News
Funding & FinancialsVascular BioSciences's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsVascular BioSciences's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com